Cardax Inc. appointed Makarand Jawadekar and Elona Kogan to its board.
Jawadekar, who has worked at Pfizer Inc. for 28 years, has experience in pharmaceutical research and development as well as knowledge of working in U.S., Europe, India and other parts of Asia, including Japan and China.
Kogan has been part of senior legal and operating positions at ARIAD Pharmaceuticals Inc. and Avanir Pharmaceuticals Inc.
Honolulu-based Cardax is a life sciences company focused on developing astaxanthin, an anti-inflammatory medicine.
